2.44 USD
+0.02 (+0.83%)
ChartMill assigns a Buy % Consensus number of 43% to XBIO. The Buy consensus is the weighted average rating of the current analysts ratings.
XBIO was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about XBIO.
In the previous month the buy percentage consensus was at a similar level.
XBIO was analyzed by 6 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-09 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-03-20 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-12-05 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-22 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-08-20 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-05-16 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-04-11 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-05-02 | HC Wainwright & Co. | Maintains | Buy |
XENETIC BIOSCIENCES INC / XBIO FAQ
How do analysts rate XENETIC BIOSCIENCES INC (XBIO)?
The consensus rating for XENETIC BIOSCIENCES INC (XBIO) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts have analysed XENETIC BIOSCIENCES INC (XBIO)?
The number of analysts covering XENETIC BIOSCIENCES INC (XBIO) is 6.